Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Schiffman, James Gibson, Kevin King, Robert Gottlieb

Gregory Schiffman has left his various senior executive positions at Affymetrix to take on the role of senior vice president and chief financial officer at Dendreon, a Seattle-based drug developer.
 
Affymetrix said last week that Schiffman resigned, effective immediately, from his posts as executive vice president, CFO, and treasurer, as well as other positions he holds at Affy subsidiaries.
 
The company said James Gibson will take over the role of principal accounting officer from his position as vice president of accounting and corporate controller. Gibson formerly served as director of finance and controller at Netflix.
 
Affy said it intends to start seeking candidates for the CFO and principal financial officer immediately.
 
Before working at Affymetrix, Schiffman held vice president positions at Applied Biosystems, Hewlett Packard, and IBM.
 
Affy also announced this week that Kevin King has been appointed president of the firm’s life sciences business and executive vice president. He previously served as president and CEO of Thomson Healthcare. Before that, King was vice president and general manager of global clinical systems for GE Healthcare.
 

 
Paris-based IntegraGen has appointed Robert Gottlieb to serve as CEO of the company’s US expansion effort, the firm said this week.
 
Gottlieb will take the helm at IntegraGen, Inc., which will be based in New York. He will continue to serve the parent company as vice president of global sales and marketing.
 
Gottlieb has worked at Abbott Laboratories, General Electric, Becton Dickinson, and Roche Diagnostics
 


 
Note to Readers: This is the last issue of BioCommerce Week to publish in 2006. The next issue of the newsletter will appear on Wednesday, Jan. 3.
The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.